SEC Form 4 · accession 0001437749-16-027695
Impax Laboratories, LLC · IPXL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leslie Z Benet
Director
Period of report
Mar 14, 2016
Accepted (ET)
Mar 15, 2016 · 2:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001003642
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 14, 2016 | M | 3,500 | $6.55 | A | 15,850 | D | |
| Common Stock | holding | — | — | — | 600 | I | By the Benet Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.55 | Mar 14, 2016 | M | 3,500 | D | — | May 20, 2019 | Common Stock | 3,500 | 50,000 | D |
Explanation of responses
- F1100% of the shares subject to the option are fully vested and exercisable.
Remarks
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.